Not available
Quote | Redhill Biopharma Ltd. (NASDAQ:RDHL)
Last: | $0.362 |
---|---|
Change Percent: | -1.84% |
Open: | $0.37 |
Close: | $0.362 |
High: | $0.374 |
Low: | $0.355 |
Volume: | 144,600 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Redhill Biopharma Ltd. (NASDAQ:RDHL)
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
Message Board Posts | Redhill Biopharma Ltd. (NASDAQ:RDHL)
Subject | By | Source | When |
---|---|---|---|
RedHill's RHB-102 (BEKINDA) and Opaganib Granted New Patents | midastouch017 | investorshub | 05/01/2023 12:05:58 PM |
JOHANNESBURG, April 28, 2023 /PRNewswire/ --(NASDAQ: $RDHL) ("RedHill" | midastouch017 | investorshub | 04/28/2023 4:37:20 PM |
Whatever happened to the crohns disease drug? They | seve333 | investorshub | 04/28/2023 3:18:25 PM |
Discussions for potential commercialization partners are ongoing. | midastouch017 | investorshub | 04/28/2023 12:33:27 PM |
RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results | midastouch017 | investorshub | 04/28/2023 12:26:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040 PR Newswire New Chinese patent notice of allowance issued covering opaganib in combination with immune checkpoint inhibitors (ICIs) as a method of inducing an ...